Grant requests For all grant requests other than the Brighter Tomorrow grant
The initial contact should be made by letter of inquiry stating the amount sought, purpose of the grant, and nature of the organization requesting the grant. Please include an e-mail address if available. The letter should be sent to: The Grant Committee c/o Managing Director Multiple Sclerosis Foundation 6350 North Andrews Avenue Ft. Lauderdale, Fl. 33309 If you are awarded a grant we do ask as a minimum that you provide us with semi-annual progress reports however additional criteria may apply depending on the amount and type of grant. FUNDING CYCLE All grant requests excluding the Brighter Tomorrow grant, must be received prior to November 1 of each year. If your request is funded, funding will occur prior to January 15 of the following year. LIMITATIONS AND EXCLUSIONS The Multiple Sclerosis Foundation, at its sole discretion, has the right to limit, refuse or cancel any grants made. The awarding of grants is at the determination of the Multiple Sclerosis Foundation.
PILOT GRANTS DUE DATE: AUGUST 15, 2008 Dear Lupus Researchers, The Alliance for Lupus Research (ALR) is pleased to announce that the applications for the ALR’s Pilot grants are now available online. You can also access the application at https://proposalcentral.altum.com. 2008 Program Guidelines Investigators seeking to submit grants applications will be eligible to receive a 1-year award for up to $75,000. Guidelines for application and submission are also available on the websites listed above.
Contact Us E-mail: info@lupusresearch.org U.S. mail: Alliance for Lupus Research 28 West 44th Street, Suite 501 New York, NY 10036 Tel: 212-218-2840 800-867-1743 (toll free)
Federal Services Junior Investigator Research GrantSupported by AbbottApplication Available: May 1, 2008Application Deadline: January 9, 2009DescriptionThe Federal Services Junior Investigator Research Grant Program supports research efforts critical to the study of medication adherence and persistence in older patients who receive care through the Veterans Administration, the Department of Defense, and the Public Health Service. These medication adherence and persistence studies should focus on individuals with either autoimmune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease. A secondary goal of the program is to develop and strengthen the skills of newer researchers in the federal services and foster mentoring of these researchers by more experienced senior investigators.Applications for this research grant program should emphasize study objectives that focus on optimal medication outcomes, sound research methods that support the study objectives, interdisciplinary collaborations, the potential for the project to be replicated in other federal health systems, and prudent use of grant funds.Eligibility CriteriaThe research must focus on the topic area. The proposed research must be conducted in a Veterans Administration, Department of Defense, or Public Health Service facility. The principal investigator for the project must be a licensed pharmacist, physician, or nurse. The principal investigator must be a new researcher within 5 years of completion of his/her terminal degree or postgraduate training or have professional experience greater than 5 years and no more than two externally funded research projects as a principal investigator. The senior investigator must be a licensed pharmacist, physician, or nurse. The proposed research must be submitted to an institutional review board (IRB) for approval. Evidence of IRB approval must be provided to the ASHP Foundation upon acceptance of the grant award. Grant funds will not be disbursed until evidence of IRB approval or evidence of exemption from IRB review has been received. The research must comply with the NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research. The study timeline should not exceed 2 years beyond project initiation.Funding InformationTwo $25,000 grants will be awarded. Grants are awarded to junior investigators to provide funding for research related to medication adherence and persistence studies that focus on individuals with either autoimmune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease and are not intended for long-term support of research programs. One-third of the total grant will be provided with the notice of the award. One-third will be provided following receipt of a written progress report submitted at the midpoint of the timeline for study completion. The remaining one-third will be provided upon receipt of a final report that is due within 60 days of project completion.Application ProcessPharmacists, physicians, and nurses interested in applying for funding should refer to the request for proposals and application instructions for full eligibility requirements and application procedures. Please check the Programs Calendar periodically for information about future offerings.Selection CriteriaGrant applications will be judged by a selection panel using the following criteria: • Rationale-10 points• Significance-10 points• Hypothesis/Objectives-20 points• Study Methods-40 points• Project Scope and Timeline-5 points• Personnel and Facilities-15 pointsDeadlinesDeadline: January 9, 2009
American Society of Health-System Pharmacists (ASHP) Research and Education Foundation7272 Wisconsin AvenueBethesda, Maryland 20814Phone: (301) 664-8612Fax: (301) 634-5712E-mail: foundation@ashp.orgWeb site: www.ashpfoundation.org
Scleroderma Foundation New Investigator Grant
Purpose: The Scleroderma Foundation is seeking applications from promising new investigators who hold faculty or equivalent positions and who wish to pursue a career in research related to systemic sclerosis (SSc, scleroderma). This grant will support promising research that is likely to lead to individual research project grants. Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are not eligible. These new investigator grants may not be used to support thesis or dissertation research or fellowship training. Applicants must have a doctoral degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences and must have completed a postdoctoral fellowship by the grant award date. Applicants who have been a Principal Investigator on grants from the Scleroderma Foundation or other national, private or government agencies other than fellowship grants are not eligible for this award. Investigators who have questions about eligibility should contact the Scleroderma Foundation (see below). Mechanism of Support: Applicants may request up to $50,000 (Up to 8% of the Direct Costs per year of award may be set aside as indirect costs. The indirect costs will be subtracted from the yearly total (up to $50,000) of the award.) per year for up to three years (total for three years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek continuing support for research through other grant mechanisms through private or government agencies. Replacement of the Principal Investigator on this award is not permitted. There will be no routine escalation for future years. Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications meeting the stated eligibility requirements. Research Objectives: The Scleroderma Foundation New Investigator Grant is designed to facilitate the entry of promising new investigators into areas of research related to SSc.
Appropriate research areas may include but are not limited to the following as they relate to scleroderma:
Vascular manifestations. Studies of animal models. Therapeutic modalities. Mechanisms of end organ damage. Immunologic studies. Endothelial cell biology. Fibroblast biology. Models and markers of gender and genetic factors. Cell signaling. Epidemiology studies. Matrix biology. Stem cell biology. Health services research (e.g. quality of life, health care delivery.) Study of clinical manifestation. 300 Rosewood Drive, Suite 105, Danvers, MA 01923 · Phone 978-463-5843 · 800-722-HOPE (4673)
Scleroderma Foundation Established Investigator Grant
Purpose: The Scleroderma Foundation is seeking applications from promising established investigators both inside and outside the field of SSc research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to SSc. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources. Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are eligible. Applicants must have a doctorate degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences, must have completed a postdoctoral fellowship, have been Principal Investigator on grants from the Scleroderma Foundation or other national, private or government agencies in the past. Investigators who have questions about eligibility should contact the Scleroderma Foundation (see below). Mechanism of Support: Applicants may request up to $75,000 (Up to 8% of the Direct Costs per year of award may be set aside as indirect costs. The indirect cost amount will be subtracted from the yearly total [up to $75,000) of the award) per year for up to two years (total for 2 years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek more substantial continuing support for research through other grant mechanisms through private or government agencies. Replacement of the Principal Investigator on this award is not permitted. There will be no routine escalation for future years. Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications meeting the stated eligibility requirements. Research Objectives: The Scleroderma Foundation Innovative Grant is designed to facilitate highly innovative or highly relevant and meritorious pilot projects by established investigators in areas of research related to SSc that will culminate in more substantial funding from Federal or non-federal granting agencies such as the National Institutes of Health, National Science Foundation and the Department of Defense or Veterans Affairs.
Vascular manifestations. Studies of animal models. Therapeutic modalities. Mechanisms of end organ damage. Immunologic studies. Endothelial cell biology. Fibroblast biology. Models and markers of gender and genetic factors. Cell signaling. Epidemiology studies. Matrix biology. Stem cell biology. Health services research (e.g. quality of life, health care delivery.) Study of clinical manifestation.
300 Rosewood Drive, Suite 105, Danvers, MA 01923 · Phone 978-463-5843 · 800-722-HOPE (4673)
Vasculitis Foundation Research Grant Program The purpose of the VF Research Grant Program is to provide one or two year seed grants to support pilot studies in researching the: etiology epidemiology diagnosis treatment, including approaches that would prevent complications, and development of coping skills for living with this disease Maximum awards will be $50,000 for 12 months. Some awards will be available for two years. The Foundation's hope is that the results of the research supported by the Research Grant Program will lead to, and provide the basis for, much larger multi-year studies that would be funded by larger agencies like The National Institutes of Health. Suitable applicants will be medical researchers in areas such as, but not limited to, rheumatology, immunology, nephrology, otolaryngology, pulmonary and respiratory diseases, and internal medicine. Applications will be reviewed annually. The deadline for submitting applications is Monday, August 18, 2008. Grant policies and application forms needed to respond to this RFP are available from the Vasculitis Foundation P.O. Box 28660 Kansas City, MO 64188-8660.
Research Policies The goals of the VF Research Grant Program are to improve the quality of life for patients with vasculitis and ultimately find the causes and cures for vasculitis. We welcome applications for our grants once a year and this year they are due Monday, August 18, 2008. The applications are evaluated by the Research Advisory Committee whose members are physicians in various fields and are familiar with the problems of vasculitis patients and are familiar with the research in this field. They evaluate and rank each application and forward their recommendations to the VF Research Committee, which then decides which applications can be funded and presents these recommendations to the VF Board of Directors for approval. The criteria for funding are very strict. The proposed studies must be planned around a sound hypothesis, must use scientific methods, and must have evidence that supports the hypothesis. The track record of the investigator must demonstrate honesty and ability to produce results and there must be infrastructure present at the institution to strongly support the study. The study may be directed exclusively at one vasculitis disease which could have overlap with other diseases or toward a basic problem that could affect all vasculitis diseases.
Vasculitis Foundation | PO Box 28660 | Kansas City, MO 64188 | 1.800.277.9474
Healthcare Professionals: Research FellowshipsResearch Fellowships for nurses, medical students and post-doctoral research are awarded annually. The purpose of these research awards is to attract physicians, PhD scientists and allied heath professionals into conducting research into Myasthenia Gravis or related conditions.Post-Doctoral Fellowship:A qualified candidate desiring training in Myasthenia Gravis research first finds a scientist with an established research program who will agree to serve as a mentor and supervise the proposed research plan. The research plan can be basic or clinical research. The Research Committee is appointed by the Chair of the Medical Advisory Board. Scientists are chosen for this committee on the basis of their ability and their special knowledge and experience in Myasthenia Gravis. This twelve-month post-doctoral fellowship is awarded for clinical or basic research related to MG or related neuromuscular disorders. Research may be concerned with the neuromuscular transmission, immunology, molecular or cell biology of the neuromuscular synapse, or the etiology/pathology or diagnosis of mg.Funding of Post-Doctoral Fellowships is dependent upon available funding. Please contact the MGFA National Office at (800) 541-5454 or mgfa@myasthenia.org before completing the application.
Annual deadline for applications is October 1.
Myasthenia Gravis Foundation of America1821 University Ave. W., Suite S256St. Paul, MN 55104Telephone: (651)917-6256 or (800)541-5454Fax: (651)917-1835Email: mgfa@myasthenia.org
Healthcare Professionals: Research Fellowships Research Fellowships for nurses, medical students and post-doctoral research are awarded annually. The purpose of these research awards is to attract physicians, PhD scientists and allied heath professionals into conducting research into Myasthenia Gravis or related conditions.
Nursing Fellowship:These fellowships are awarded annually to nurses or nursing students interested in studying problems encountered by patients with MG or related neuromuscular conditions.
1
